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Introduction
Enterococci spp. cause serious infections in ICU envir-
onment. Among them, Enterococcus faecium may con-
stitute a problem when choosing empirical treatment. In
addition, vancomycin-resistant Enterococci is growing as
an epidemiological problem.
Objectives
To identify risk factors for acquisition of an E. Faecium
infection in patients admitted to Intensive Care Unit
(ICU).
Methods
We analyzed retrospective data from patients admitted
to a polivalent ICU during a 4-year period. We specifi-
cally analyzed those patients with an infection during
their ICU stay and search for factors related to the isola-
tion of E. faecium from clinical samples.
Results
We studied 841 patients, 21 of them (2.5 %) with an E.
Faecium infection. No E. faecium vancomycin resistance
was found.
Patients with E. Faecium isolation were older (69.5 vs
64), infections had been acquired in the hospital, were sur-
gical patients in higher proportion and had longer ICU
stay (81 vs 44.3 % p 0.001 and 57.1 vs 27.5 % p 0.003 and
6 (3-11) vs 13 (6-25) p 0.001 respectively), had received
parenteral nutrition (43 v 13 % p 0.001) and were mal-
nourished in higher rate (25 v 4.2 % p 0.001) Prior use of
piperacilina-tazobactam, carbapenem or linezolid were
found more frequently in E. Faecium-infected patients
(52.4 vs 24.1 % p 0.003 and 66.7 vs 20.6 % p 0.001) ESBL
isolation coexisted more frequently in patients with E. Fae-
cium infection. Mortality rate was higher in patients with
E. faecium infection (57 vs 25.6 % p 0.001).
Logistic regression analysis showed nosocomial admis-
sion, prior use of piperaciline-tazobactam or carbape-
nem and ESBL isolation as independent risk factors for
E. faecium infection. E. faecium infection was not inde-
pendently associated with mortality.
Conclusions
Non-community admissions and prior exposure to
piperaciline-tazobactam and carbapenem resulted being
associated with isolation of E. faecium in our patients.
ESBL isolation appeared independently associated with
E. faecium, probably because both bacteria share ways
of selection. Controlling raising incidence of E. faecium
may prevent vancomycin-resistant Enterococci spread,
not still a problem in our environment.
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